Mawer Investment Management Ltd. Has $8.67 Million Stock Holdings in Humana Inc. (NYSE:HUM)

Mawer Investment Management Ltd. trimmed its position in shares of Humana Inc. (NYSE:HUM - Free Report) by 28.5% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 27,373 shares of the insurance provider's stock after selling 10,929 shares during the period. Mawer Investment Management Ltd.'s holdings in Humana were worth $8,670,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in the business. Quest Partners LLC acquired a new stake in shares of Humana in the third quarter worth $701,000. S&CO Inc. grew its position in Humana by 16.4% in the 3rd quarter. S&CO Inc. now owns 33,760 shares of the insurance provider's stock worth $10,693,000 after purchasing an additional 4,762 shares during the last quarter. Thrivent Financial for Lutherans increased its holdings in shares of Humana by 55.6% during the 3rd quarter. Thrivent Financial for Lutherans now owns 600,317 shares of the insurance provider's stock worth $190,145,000 after purchasing an additional 214,535 shares during the period. AM Squared Ltd raised its position in shares of Humana by 200.0% during the third quarter. AM Squared Ltd now owns 300 shares of the insurance provider's stock valued at $95,000 after buying an additional 200 shares during the last quarter. Finally, Mutual of America Capital Management LLC lifted its stake in shares of Humana by 12.4% in the third quarter. Mutual of America Capital Management LLC now owns 21,717 shares of the insurance provider's stock valued at $6,879,000 after buying an additional 2,395 shares during the period. 92.38% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of research analysts recently commented on the company. Royal Bank of Canada cut their target price on Humana from $400.00 to $265.00 and set an "outperform" rating for the company in a research note on Tuesday, October 8th. Leerink Partners lowered Humana from an "outperform" rating to a "market perform" rating and dropped their price objective for the stock from $400.00 to $250.00 in a research note on Wednesday, October 2nd. Oppenheimer reduced their price target on shares of Humana from $400.00 to $280.00 and set an "outperform" rating on the stock in a research report on Thursday, October 3rd. KeyCorp started coverage on shares of Humana in a research note on Friday, October 11th. They set a "sector weight" rating on the stock. Finally, Bank of America raised Humana from an "underperform" rating to a "neutral" rating and boosted their price objective for the stock from $247.00 to $308.00 in a report on Wednesday, November 6th. Twenty investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and an average price target of $315.86.

Humana Stock Performance

Humana stock traded down $4.32 during trading hours on Monday, hitting $271.35. The company had a trading volume of 1,929,765 shares, compared to its average volume of 1,875,254. The firm has a market cap of $32.67 billion, a PE ratio of 24.42, a PEG ratio of 2.17 and a beta of 0.52. The firm has a 50-day moving average of $281.36 and a 200 day moving average of $331.94. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.76 and a quick ratio of 1.76. Humana Inc. has a one year low of $213.31 and a one year high of $527.18.

Humana (NYSE:HUM - Get Free Report) last posted its earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share for the quarter, topping analysts' consensus estimates of $3.48 by $0.68. Humana had a return on equity of 13.20% and a net margin of 1.18%. The company had revenue of $29.30 billion during the quarter, compared to the consensus estimate of $28.66 billion. On average, sell-side analysts expect that Humana Inc. will post 15.86 earnings per share for the current year.

Humana Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Tuesday, December 31st will be paid a dividend of $0.885 per share. The ex-dividend date of this dividend is Tuesday, December 31st. This represents a $3.54 dividend on an annualized basis and a yield of 1.30%. Humana's dividend payout ratio (DPR) is presently 31.36%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.